The Board of Directors of Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) ("Duopharma Biotech") wishes to announce that all the resolutions as set out in the Notice of the Eighteenth Annual General Meeting ("18thAGM") dated 29 April 2019have been passed by the shareholders of Duopharma Biotech at the AGM held today.

The voting in respect of all the resolutions were carried out by way of poll and the results were validated by Asia Securities Sdn. Berhad, the independent scrutineer appointed byDuopharma Biotech.

Please refer to the Appendix 1for the results of the poll.

This announcement is dated 31 May 2019.

Remarks in respect ofthisamended announcement:-

An amendment has been made to paragraph 1 under the section entitled "Outcome of Meeting" whereby the date of the Notice of the Eighteenth Annual General Meeting ("18th AGM") has been amended to 29 April 2019.

As announced by the Company on 29 April 2019, the date of the Notice of 18th AGM was 29 April 2019.